[Clinical evaluation of immunosuppressive factors (IAP-immunosuppressive acidic protein, IS-immunosuppressive substance) in head and neck cancer]. 1989

T Saito, and Y Dake, and H Kakiuti, and Y Kato, and K Kuki, and Y Hayashi, and M Yokota, and K Kinoshita, and S Kuki, and T Kimura

It is reported that the levels of serum IAP and IS are useful parameters to evaluate the prognosis along with the clinical course of tumor bearing patients. Serum IAP and IS were examined in 149 patients with head and neck cancer. The level of serum IAP and IS increased in patients with not only advanced stages, but also poor prognosis. In general, the patients with death or recurrence had higher levels of serum IAP and IS than those with good prognosis. It is concluded that serum IAP and IS well reflect the immunological condition and clinical course of patients with cancer and may be one of the useful parameter for them.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D005260 Female Females
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

T Saito, and Y Dake, and H Kakiuti, and Y Kato, and K Kuki, and Y Hayashi, and M Yokota, and K Kinoshita, and S Kuki, and T Kimura
October 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
T Saito, and Y Dake, and H Kakiuti, and Y Kato, and K Kuki, and Y Hayashi, and M Yokota, and K Kinoshita, and S Kuki, and T Kimura
August 1983, Gan no rinsho. Japan journal of cancer clinics,
T Saito, and Y Dake, and H Kakiuti, and Y Kato, and K Kuki, and Y Hayashi, and M Yokota, and K Kinoshita, and S Kuki, and T Kimura
January 1985, Auris, nasus, larynx,
T Saito, and Y Dake, and H Kakiuti, and Y Kato, and K Kuki, and Y Hayashi, and M Yokota, and K Kinoshita, and S Kuki, and T Kimura
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
T Saito, and Y Dake, and H Kakiuti, and Y Kato, and K Kuki, and Y Hayashi, and M Yokota, and K Kinoshita, and S Kuki, and T Kimura
July 2010, Nihon rinsho. Japanese journal of clinical medicine,
T Saito, and Y Dake, and H Kakiuti, and Y Kato, and K Kuki, and Y Hayashi, and M Yokota, and K Kinoshita, and S Kuki, and T Kimura
July 1983, The Japanese journal of surgery,
T Saito, and Y Dake, and H Kakiuti, and Y Kato, and K Kuki, and Y Hayashi, and M Yokota, and K Kinoshita, and S Kuki, and T Kimura
May 1991, Hinyokika kiyo. Acta urologica Japonica,
T Saito, and Y Dake, and H Kakiuti, and Y Kato, and K Kuki, and Y Hayashi, and M Yokota, and K Kinoshita, and S Kuki, and T Kimura
October 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
T Saito, and Y Dake, and H Kakiuti, and Y Kato, and K Kuki, and Y Hayashi, and M Yokota, and K Kinoshita, and S Kuki, and T Kimura
September 1986, Gan no rinsho. Japan journal of cancer clinics,
T Saito, and Y Dake, and H Kakiuti, and Y Kato, and K Kuki, and Y Hayashi, and M Yokota, and K Kinoshita, and S Kuki, and T Kimura
September 1984, Nihon Kyobu Shikkan Gakkai zasshi,
Copied contents to your clipboard!